Lexaria Bioscience Corp (LEXX) is a biotechnology company listed on US.
Latest reported LEXX revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXX currently screens at market cap $14.9M.
Use this LEXX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LEXX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LEXX SEC filings page. Lician reads the product cache first so this HTML stays unique to Lexaria Bioscience Corp even when a live quote feed is slow.
Latest cached year on this hub. Full LEXX income, balance, and cash tables.